Respiratory Patients Clinical Trial
Official title:
Evaluation of EarlySense EverOn™ System in Medical / Surgical Ward
Verified date | March 2008 |
Source | EarlySense Ltd. |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Observational |
The EverOn™ system developed by EarlySense, Ltd., the sponsor of this study, is intended to
assist hospitals to better address and improve recognition and response to changes in a
patient's condition.
The system, monitors the patient while in bed consists of a contact-free sensor that is
placed under the bed mattress and identifies respiratory and heart rates, degree of
patient's movement or agitation while in bed as well as patient's actual exit out of the
bed. The EverOn system does not require a physical contact with the patient, eliminating the
need for any direct contact electrodes, leads, cuffs or nasal cannulae.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | May 2010 |
Est. primary completion date | March 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: 1. Age above 18 years. 2. Patients not monitored continuously by telemetry, vital sign monitor or oximetry. 3. Patients not requiring special mattresses (e.g. airflow). 4. The patient or a legal guardian is ready to sign the Informed Consent. Exclusion Criteria: 1. Patients that at the judgment of the staff in the evaluating unit, are not able to communicate coherently and respond to nurses' questions. 2. Patients monitored continuously by telemetry, vital sign monitor or oximetry. 3. Patients requiring special mattresses. |
Observational Model: Case-Only, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
United States | MetroWest Medical Center | Framingham | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
EarlySense Ltd. |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01904344 -
Clinical Validation of New Breathing Sensors in Patients With Respiratory Insufficiency
|
N/A |